medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2011, Number 3

<< Back Next >>

Rev ADM 2011; 68 (3)

Sharps Safety Guidelines for Infection Control and Occupational Exposure in Dental Health-Care Settings

Martínez MHR, Garza CG, Correa L, Treviño AMG, Rivera SG

Language: Spanish
References: 11
Page: 115-118
PDF size: 104.50 Kb.


ABSTRACT

Biosecurity measures are intended to decrease the risk of transmission of microorganisms from recognized or unrecognized sources of infection in dental clinics araising from accidents involving exposure to blood and body fluids. This paper proposes a guideline aimed primarily at promoting education on sharps safety amongst dental clinic staff and at preventing the transmission of pathogens during the use of such instruments. These recommendations are intended for healthcare professionals engaged in clinical dental practice.


REFERENCES

  1. Younai FS. Health care associated transmission of hepatitis B & C viruses in dental care (dentistry). Clin Liver Dis 2010;14:93-104. Patton LL. HIV disease. Dent Clin North Amer 2003;47:467-492.

  2. Cleveland JL, Cardo DM. Occupational exposures to human immunodeficiency virus, hepatitis B, and hepatitis C virus: risk, prevention, and management. Dent Clin North Amer 2003;47:687-696.

  3. Thomas MV, Jarboe G, Frazer RQ. Infection control in the dental office. Dent Clin North Amer 2008;52:609-628.

  4. Porter K, Scully C, Theyer Y, Porter S. Occupational injuries to dental personnel. J Dent 1990;18:258-262.

  5. Nuttall NM, Gilbert AD. Final year dental students views on cross infection precautions. J Dent 1993;21:105-110.

  6. Weiss SH, Leschek JD. HIV era occupational exposures and risks HIV. AIDS and Other Manifestations of HIV Infection, Ed Wormers GP, 4th Edition, 2003. pp. 811-838.

  7. Mosca NG, Hathorn AR. HIV positive patients: Dental management considerations. Dent Clin North Amer 2006;50:635-657.

  8. Hoffman H, Konczer A. Risk factors in individuals with a positive HCV test. Serodiagn Immunother Infect Dis 1993;5:145-149.

  9. Gunson RN, Shouval D, Roggendorf M, Zaaijer H, Nicholas H, Holzmann H, Schryver A, Reynders D, Connell J, Gerlich WH, Marinho RT, Tsantoulas D, Rigopoulou E, Rosenheim M, Valla D, Puro V, Struwe J, Tedder P, Aitken C, Alter M. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003;27:213-230.

  10. Hattori J, Shiino T, Gatanaga H, Yoshida S, Watanabe D, Minami R, Sadamasu K, Kondo M, Mori H, Ueda M, Tateyama M, Ueda A, Kato S, Ito T, Oie M, Takata N, Hayashida T, Nagashima M, Matsuda M, Ibe S. Trends in transmitted drug resistant HIV-1 and demographic characteristics of newly diagnosed patients: Nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res 2010;88:72-79.

  11. CDC. Public Health Service. Management of possible sexual, injecting-drug use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. MMWR 1998;47(RR-17): 1-12.




2020     |     www.medigraphic.com